论文信息 - BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression - 字舞流文

BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression

D. Wiederschain | F. Nestle | Sharad K Sharma | S. Hashmueli | Hongjin Qu | Y. Sapir | Motti Hakim | R. Greco | D. Alishekevitz | Tehila Ben Moshe | T. Peretz | I. Mandel | Dana Haves Ziv | I. Goldshtein | Anna Fridman Dror | Itay Friedman | L. Pao